TREATMENT OF HIGH-GRADE NON-HODGKIN LYMPHOMA - RESULTS OF A PHASE-II AND A PHASE-III TRIAL

被引:0
作者
KOPPLER, H [1 ]
PFLUGER, KH [1 ]
HAVEMANN, K [1 ]
ESCHENBACH, I [1 ]
PFAB, R [1 ]
LENNERT, K [1 ]
WELLENS, W [1 ]
SCHMIDT, M [1 ]
GASSEL, WD [1 ]
KOLB, R [1 ]
HASSLER, R [1 ]
SCHUMACHER, K [1 ]
VONSPETH, G [1 ]
GROPP, C [1 ]
HIRSCHMANN, WD [1 ]
GOSSMANN, HH [1 ]
OHL, S [1 ]
DRINGS, P [1 ]
HOSSFELD, DK [1 ]
BRUNTSCH, U [1 ]
机构
[1] UNIV MARBURG,ZENTRUM INNERE MED,HAMATOL ONKOL ABT,D-3550 MARBURG,FED REP GER
来源
BLUT | 1988年 / 57卷 / 04期
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:220 / 220
页数:1
相关论文
共 50 条
[31]   RATE OF POLYMORPHIC TRANSFORMATION BETWEEN PHASE-II AND PHASE-III OF HEXACHLOROETHANE [J].
KOGA, Y ;
MIURA, RM .
JOURNAL OF THE CHEMICAL SOCIETY-FARADAY TRANSACTIONS I, 1978, 74 :1913-1921
[32]   NON-HODGKIN LYMPHOMA IN THE INFANT PHASE [J].
GUAZZELLI, C ;
LIPPI, A ;
GRAZIANI, A ;
ROSI, A ;
TUCCI, F ;
ROSATI, GV .
RIVISTA ITALIANA DI PEDIATRIA-ITALIAN JOURNAL OF PEDIATRICS, 1984, 10 (05) :620-621
[33]   Results of the SMARTE-R-CHOP-14 trial of the German high-grade Non-Hodgkin Lymphoma study group (DSHNHL) [J].
Pfreundschuh, M. ;
Poeschel, V ;
Zeynalova, S. ;
Viardot, A. ;
Haenel, M. ;
Keller, U. ;
Reiser, M. ;
Murawski, N. ;
Loeffler, M. ;
Schubert, J. .
ONKOLOGIE, 2010, 33 :204-204
[34]   Results of SMARTE-R-CHOP-14 trial of the German high-grade non-Hodgkin lymphoma study group (DSHNHL) [J].
Pfreundschuh, M. ;
Poeschel, V. ;
Zeynalova, S. ;
Viardot, A. ;
Haenel, M. ;
Keller, U. ;
Reiser, M. ;
Murawski, N. ;
Loeffler, M. ;
Schubert, J. .
JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
[35]   FLUDARABINE IN RELAPSED LOW-GRADE NON-HODGKIN LYMPHOMAS - A PHASE-II STUDY OF THE GERMAN LOW-GRADE LYMPHOMA STUDY-GROUP [J].
POTT, C ;
UNTERHALT, M ;
SANDFORD, D ;
MARKERT, H ;
FREUND, M ;
ENGERT, A ;
GASSMANN, W ;
HOLTKAMP, W ;
SEUFERT, M ;
HELLRIEGEL, K ;
KNAUF, B ;
NIEBERDING, R ;
EMMERICH, B ;
KOCH, P ;
WORMANN, B ;
HIDDEMANN, W .
BLOOD, 1993, 82 (10) :A575-A575
[36]   Phase I/II Trial of Lenalidomide and Ofatumumab for the Treatment of Relapsed or Refractory Non-Hodgkin's Lymphoma (NHL) [J].
Kallam, Avyakta ;
Meza, Jane ;
Bierman, Philip ;
Lunning, Matthew A. ;
Bociek, R. Gregory ;
Armitage, James Olen ;
Vose, Julie M. .
BLOOD, 2017, 130
[37]   Cologne high-dose sequential chemotherapy in relapsed and refractory Hodgkin's and aggressive non-Hodgkin's lymphoma -: Results of a multicenter phase-II study. [J].
Josting, A ;
Rudolph, C ;
Mapara, M ;
Ko, Y ;
Söhngen, D ;
Dorken, B ;
Diehl, V ;
Engert, A .
BLOOD, 2001, 98 (11) :681A-681A
[38]   Sequential high dose chemotherapy as initial treatment for aggressive sub-types of Non-Hodgkin Lymphoma: results of the international randomized phase III trial (MISTRAL) [J].
Betticher, D. C. ;
Martinelli, G. ;
Radford, J. A. ;
Kaufmann, M. ;
Dyer, M. J. S. ;
Kaiser, U. ;
Aulitzky, W. E. ;
Beck, J. ;
von Rohr, A. ;
Kovascovics, T. ;
Cogliatti, S. B. ;
Cina, S. ;
Maibach, R. ;
Cerny, T. ;
Linch, D. C. .
ANNALS OF ONCOLOGY, 2006, 17 (10) :1546-1552
[39]   A man with hereditary exostoses and high-grade non-Hodgkin's lymphoma of the bone [J].
K. Neben ;
M. Werner ;
L. Bernd ;
V. Ewerbeck ;
G. Delling ;
A. Ho .
Annals of Hematology, 2001, 80 :682-684
[40]   Modeling combined chemo- and immunotherapy of high-grade non-Hodgkin lymphoma [J].
Roesch, Katja ;
Scholz, Markus ;
Hasenclever, Dirk .
LEUKEMIA & LYMPHOMA, 2016, 57 (07) :1697-1708